Corvus Pharmaceuticals In... (CRVS)
NASDAQ: CRVS
· Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT
Corvus Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 14.69M | 5M | 8.74M | 4.68M | 14.84M | 7.46M | 12.62M | 20.11M | 7.66M | 9.65M | 13.16M | 24.59M | 28.48M | 31.46M | 63.46M | 72.3M | 58.91M | 45.1M |
Short-Term Investments | 59.72M | 39.21M | 43.22M | 36.97M | 32.41M | 14.67M | 14.53M | 12.06M | 29.36M | 24.81M | 29.14M | 25.03M | 28.25M | 31.48M | 5.99M | 4.03M | 7.54M | 22.86M |
Long-Term Investments | 11.79M | 12.06M | 12.54M | 15.19M | 15.4M | 16.07M | 16.12M | 17.07M | 18.02M | 20.23M | 21.88M | 25.91M | 30.18M | 33.37M | 34.27M | 36.33M | 38.05M | 37.13M |
Other Long-Term Assets | 626K | 629K | 632K | 252K | 129K | 89K | 89K | 89K | 129K | 1.54M | 1.84M | 248K | 236K | 236K | 2.55M | 279K | 316K | 1.08M |
Receivables | 86K | 227K | 216K | 70K | 122K | 58K | 63K | 50K | 34K | 467K | 633K | 534K | 429K | 445K | 539K | 323K | 46K | 126K |
Inventory | n/a | n/a | n/a | n/a | n/a | 22.82M | n/a | 662K | 723K | -598K | -735K | 724K | 1.34M | 848K | 32K | 2.01M | 2.53M | 506K |
Other Current Assets | 1.29M | 458K | 548K | 812K | 240K | -22.56M | 220K | -448K | 136K | 131K | 102K | 397K | 395K | 130K | 128K | 98K | 80K | 208K |
Total Current Assets | 75.78M | 45.49M | 54.41M | 42.92M | 48.26M | 22.85M | 27.96M | 33.09M | 37.91M | 34.47M | 42.3M | 51.27M | 58.88M | 64.37M | 69.45M | 78.76M | 69.12M | 68.81M |
Property-Plant & Equipment | 1.26M | 1.26M | 1.33M | 455K | 770K | 1.08M | 1.39M | 1.69M | 1.99M | 1.95M | 2.22M | 2.91M | 3.24M | 3.32M | 3.19M | 3.96M | 1.91M | 2.22M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.68M | 13.95M | 14.5M | 15.89M | 16.3M | 17.23M | 17.6M | 18.85M | 20.13M | 23.73M | 25.94M | 29.08M | 33.66M | 36.92M | 40M | 40.57M | 40.27M | 40.43M |
Total Assets | 89.46M | 59.44M | 68.91M | 58.81M | 64.56M | 40.08M | 45.55M | 51.94M | 58.04M | 58.2M | 68.24M | 80.35M | 92.54M | 101.29M | 109.45M | 119.32M | 109.39M | 109.24M |
Account Payables | 3.14M | 1.31M | 2.58M | 1.87M | 1.21M | 1.61M | 1.52M | 1.4M | 2.1M | 1.41M | 1.98M | 4.23M | 2.65M | 2.19M | 1.56M | 2.33M | 2.87M | 4.91M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.32M | n/a | n/a | 8.39M | n/a | n/a | 6.96M | 7.83M | 8.06M | 7.28M |
Short-Term Debt | 355K | n/a | n/a | n/a | n/a | 1.04M | 1.37M | 1.34M | 1.3M | n/a | n/a | 1.18M | 1.14M | 1.09M | n/a | n/a | 1.15M | 1.11M |
Other Current Liabilities | 4.19M | 4.8M | 30.02M | 44.18M | 7.35M | -272K | 1.91M | -323K | 2.36M | 1.04M | 6.43M | 6.05M | 3.98M | 3.95M | 5.24M | 6.55M | 5.56M | 5.17M |
Total Current Liabilities | 8.51M | 9.28M | 35.4M | 46.41M | 13.34M | 6.72M | 6.87M | 7.3M | 7.86M | 7.03M | 12.13M | 13.98M | 10.16M | 9.27M | 12.29M | 11.3M | 12.36M | 13.92M |
Long-Term Debt | 728K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 700K | n/a | 1.37M | 1.69M | 2M | 2.3M | 2.6M | 2.87M | 631K | 935K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -700K | n/a | -1.37M | -1.69M | -2M | -2.3M | -2.6M | -2.87M | -631K | -935K |
Total Long-Term Liabilities | 728K | 834K | 937K | n/a | n/a | 1.04M | n/a | 354K | 700K | 2.3M | 1.37M | 1.69M | 2M | 2.3M | 2.6M | 2.87M | 631K | 935K |
Total Liabilities | 9.23M | 10.11M | 36.34M | 46.41M | 13.34M | 6.72M | 6.87M | 7.65M | 8.56M | 9.33M | 12.13M | 15.67M | 12.15M | 11.57M | 12.29M | 14.18M | 12.99M | 14.85M |
Total Debt | 1.08M | 1.15M | 1.12M | 354K | 700K | 1.04M | 1.37M | 1.69M | 2M | 2.3M | 2.6M | 2.87M | 3.13M | 3.39M | 3.65M | 3.88M | 1.78M | 2.05M |
Common Stock | 7K | 7K | 7K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K |
Retained Earnings | -389.81M | -381.82M | -397.01M | -384.9M | -344.68M | -340.42M | -334.72M | -328.06M | -322.06M | -315.56M | -307.69M | -297.87M | -283.04M | -274.68M | -266.38M | -257.14M | -246.47M | -234.72M |
Comprehensive Income | -1.15M | -1.25M | -1.29M | -738K | -1.35M | -1.27M | -967K | -1.44M | -1.37M | -434K | -563K | -1.19M | 339K | 1.99M | 1.87M | 1.38M | 1.39M | 6K |
Shareholders Equity | 80.23M | 49.33M | 32.57M | 12.41M | 51.23M | 33.36M | 38.68M | 44.29M | 49.48M | 48.87M | 56.12M | 64.68M | 80.39M | 89.72M | 97.16M | 105.15M | 96.4M | 94.39M |
Total Investments | 71.51M | 51.27M | 55.76M | 52.16M | 47.81M | 30.74M | 30.65M | 29.14M | 47.38M | 24.81M | 51.02M | 50.94M | 58.43M | 64.86M | 40.26M | 40.36M | 45.59M | 59.99M |